Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
20.9M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
18.4M
-
Shares change
-
+2.51M
-
Total reported value, excl. options
-
$762M
-
Value change
-
+$67.7M
-
Put/Call ratio
-
0.93
-
Number of buys
-
79
-
Number of sells
-
-58
-
Price
-
$41.36
Significant Holders of Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) as of Q2 2024
156 filings reported holding PRAX - Praxis Precision Medicines, Inc. - COMMON STOCK as of Q2 2024.
Praxis Precision Medicines, Inc. - COMMON STOCK (PRAX) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.4M shares
of 20.9M outstanding shares and own 88.13% of the company stock.
Largest 10 shareholders include BlackRock Inc. (1.29M shares), RA CAPITAL MANAGEMENT, L.P. (1.24M shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1.13M shares), Point72 Asset Management, L.P. (1.05M shares), VANGUARD GROUP INC (977K shares), PRICE T ROWE ASSOCIATES INC /MD/ (939K shares), STATE STREET CORP (819K shares), PERCEPTIVE ADVISORS LLC (750K shares), Verition Fund Management LLC (748K shares), and VR Adviser, LLC (706K shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.